Personalized medicine for anticoagulation therapy
نویسندگان
چکیده
منابع مشابه
Personalized medicine for cancer therapy
Antibody signatures may become sophisticated screening tools for early diagnosis and the development of personalized anticancer treatments. We used biopanning to enrich the immune response of head and neck squamous cell carcinoma (HNSCC) patients. This method revealed a HNSCC-specific antibody signature and allowed for the discovery of a novel oncogene, L23.
متن کاملPrecision Medicine for Personalized Cancer Therapy.
Precision medicine is defined as the tailoring of clinical strategies based on genomic, genetic, behavioral and environment background of individual patients. Statistics indicated that traditional clinical practices sometimes lead to poor health outcomes and a waste of medical resources. Medical waste due to unnecessary treatment or ineffective treatment amounted to 75 billion US dollars per ye...
متن کاملPersonalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics
In recent years, substantial effort has been made to better understand the influence of genetic factors on the efficacy and safety of numerous medications. These investigations suggest that the use of pharmacogenetic data to inform physician decision-making has great potential to enhance patient care by reducing on-treatment clinical events, adverse drug reactions, and health care-related costs...
متن کاملPersonalized medicine-molecular targeted cancer therapy
chemotherapy. Metastatic or advanced cancers with limited effects of radiation and chemotherapy have been the challenging issue in recent cancer therapy. In this situation, the molecular target cancer therapy has been successfully accepted for various cancers. This type of therapy is to suppress the cell proliferation or induce apoptosis of cancer cells by targeting particular molecules which p...
متن کاملPersonalized Medicine for Gliomas
Personalized medicine for cancer entails tailoring therapy for each patient based on unique features of the patient's tumor; physiologic, molecular, genetic and epigenetic. Our ability to molecularly characterize tumor cells has increased dramatically and shown that there are significant differences between samples from patients with the same tumor type. Given this extensive variability in muta...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Japanese Journal of Thrombosis and Hemostasis
سال: 2006
ISSN: 0915-7441,1880-8808
DOI: 10.2491/jjsth.17.706